1. Home
  2. HTFL

as of 12-26-2025 3:59pm EST

$29.82
$0.19
-0.63%
Stocks Nasdaq

HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.

Founded: 2007 Country:
United States
United States
Employees: N/A City: MOUNTAIN VIEW
Market Cap: 2.4B IPO Year: 2025
Target Price: $39.50 AVG Volume (30 days): 751.8K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -7.38 EPS Growth: N/A
52 Week Low/High: $25.38 - $41.22 Next Earning Date: 02-08-2026
Revenue: $161,881,000 Revenue Growth: 85.70%
Revenue Growth (this year): 40.42% Revenue Growth (next year): 22.27%

Share on Social Networks: